A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors

Clinical trial NCT06126666 · RECRUITING

Trial details

NCT number: NCT06126666
Sponsor: ABL Bio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-11-07
Primary completion: 2025-12-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.